FFO
TXG icon

Fortitude Family Office’s 10x Genomics TXG Stock Holding History

Fortitude Family Office’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.82K Sell
180
-130
-42% -$2.6K ﹤0.01% 1024
2025
Q4 		$5.06K Hold
310
– – ﹤0.01% 804
2025
Q3 		$3.62K Hold
310
– – ﹤0.01% 942
2025
Q2 		$3.59K Buy
+310
New +$2.83K ﹤0.01% 925

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fortitude Family Office's TXG Position: Q1 2026 in Review

Fortitude Family Office reduced its 10x Genomics (TXG) stake by 42% in Q1 2026, selling an estimated $2.6K and leaving 180 shares worth $3.82K. The position accounts for ﹤0.01% of the portfolio, ranked #1024.

Fortitude Family Office first reported a position in TXG in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.06K in Q4 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Fortitude Family Office held 180 shares of 10x Genomics worth $3.82K as of Q1 2026.
  • Fortitude Family Office sold 130 10x Genomics shares in Q1 2026, an estimated $2.6K.
  • 10x Genomics made up ﹤0.01% of Fortitude Family Office's portfolio in Q1 2026, its #1024 holding.
  • Fortitude Family Office first reported a position in 10x Genomics in Q2 2025 and has held it in 4 quarters since.
  • Fortitude Family Office's 10x Genomics position peaked at $5.06K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.